Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: A role for ER stress?

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 2, 2009, Pages 225-233

  Cook, Alexandra R ^a   Bardswell, Sonya C ^a   Pretheshan, Subashini ^a   Dighe, Kushal ^a   Kanaganayagam, Gajen S ^a   Jabr, Rita I ^a   Merkle, Sabine ^b   Marber, Michael S ^a   Engelhardt, Stefan ^b,c   Avkiran, Metin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiac remodelling; Endoplasmic reticulum stress; Heart failure; Infarction; Ischemia; Na+ H+ exchanger

Indexed keywords

CALRETICULIN; GLUCOSE; PROTEIN DISULFIDE ISOMERASE; SODIUM PROTON EXCHANGE PROTEIN 1; ZONIPORIDE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL PROTECTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FEMALE; HEART; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPERFUSION INJURY; SARCOLEMMA; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; ENDOPLASMIC RETICULUM; GUANIDINES; HEART FAILURE; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MUSCLE CELLS; MYOCARDIAL ISCHEMIA; PYRAZOLES; SODIUM-HYDROGEN ANTIPORTER;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 58149354168     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.10.013     Document Type: Article

References (52)

1. + exchanger. J. Mol. Cell. Cardiol. 44 (2008) 228-237
2. Leem C.H., Lagadic-Gossmann D., and Vaughan-Jones R.D. Characterization of intracellular pH regulation in the guinea-pig ventricular myocyte. J. Physiol. 517 (1999) 159-180
3. Haworth R.S., Fröhlich O., and Fliegel L. Multiple carbohydrate moieties on the Na+/H+ exchanger. Biochem. J. 289 (1993) 637-640
4. Counillon L., Pouysségur J., and Reithmeier R.A. The Na+/H+ exchanger NHE-1 possesses N- and O-linked glycosylation restricted to the first N-terminal extracellular domain. Biochemistry 33 (1994) 10463-10469
5. Petrecca K., Atanasiu R., Grinstein S., Orlowski J., and Shrier A. Subcellular localization of the Na+/H+ exchanger NHE1 in rat myocardium. Am. J. Physiol. Heart. Circ. Physiol. 276 (1999) H709-H717
6. Snabaitis A.K., D, Mello R., Dashnyam S., and Avkiran M. A novel role for protein phosphatase 2A in receptor-mediated regulation of the cardiac sarcolemmal Na+/H+ exchanger NHE1. J. Biol. Chem. 281 (2006) 20252-20262
7. Vaughan-Jones R.D., Spitzer K.W., and Swietach P. Spatial aspects of intracellular pH regulation in heart muscle. Prog. Biophys. Mol. Biol. 90 (2006) 207-224
8. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am. J. Cardiol. 83 (1999) 10G-18G
9. Scholz W., Albus U., Counillon L., Gögelein H., Lang H.J., Linz W., et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc. Res. 29 (1995) 260-268
10. Gumina R.J., Mizumura T., Beier N., Schelling P., Schultz J.L., and Gross G.J. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. J. Pharmacol. Exp. Ther. 286 (1998) 175-183
11. Knight D.R., Smith A.H., Flynn D.M., MacAndrew J.T., Ellery S.S., Kong J.X., et al. A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J. Pharmacol. Exp. Ther. 297 (2001) 254-259
12. Avkiran M. Protection of the ischaemic myocardium by Na+/H+ exchange inhibitors: potential mechanisms of action. Basic. Res. Cardiol. 96 (2001) 306-311
13. Karmazyn M., Gan X.T., Humphreys R.A., Yoshida H., and Kusumoto K. The myocardial Na+-H+ exchange: structure, regulation, and its role in heart disease. Circ. Res. 85 (1999) 777-786
14. Avkiran M., and Marber M.S. Na+/H+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J. Am. Coll. Cardiol. 39 (2002) 747-753
15. Avkiran M., Cook A., and Cuello F. Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach?. Curr. Opin. Pharmacol. 8 (2008) 133-140
16. + exchanger are resistant to cardiac ischemia-reperfusion injury. Circ. Res. 93 (2003) 776-782
17. Bell S.M., Schreiner C.M., Schultheis P.J., Miller M.L., Evans R.L., Vorhees C.V., et al. Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures. Am. J. Physiol. Cell. Physiol. 276 (1999) C788-C795
18. + exchanger and ischemia/reperfusion injury in the myocardium. Am. J. Physiol. Heart. Circ. Physiol. 292 (2007) H2237-H2247
19. Buitrago M., Lorenz K., Maass A.H., Oberdorf-Maass S., Keller U., Schmitteckert E.M., et al. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat. Med. 11 (2005) 837-844
20. Bellahcene M., Jacquet S., Cao X.B., Tanno M., Haworth R.S., Layland J., et al. Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor. J. Am. Coll. Cardiol. 48 (2006) 545-555
21. 2+ sensitivity in ventricular myocytes. Circ. Res. 100 (2007) 864-873
22. + exchanger: evidence for a receptor-mediated mechanism involving protein kinase C. Circ. Res. 79 (1996) 705-715
23. + exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT1 versus AT2 receptors. Circ. Res. 85 (1999) 919-930
24. + exchanger. Circ. Res. 86 (2000) 214-220
25. Clark J.E., Flavell R.A., Faircloth M.E., Davis R.J., Heads R.J., and Marber M.S. Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3 (MKK3). Cardiovasc. Res. 74 (2007) 466-470
26. Tanno M., Bassi R., Gorog D.A., Saurin A.T., Jiang J., Heads R.J., et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ. Res. 93 (2003) 254-261
27. Bell R.M., Clark J.E., Hearse D.J., and Shattock M.J. Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: characterisation in the bi-phasic profile of early and late protection. Cardiovasc. Res. 73 (2007) 153-163
28. + exchange prevents hypertrophy, fibrosis, and heart failure in b1-adrenergic receptor transgenic mice. Circ. Res. 90 (2002) 814-819
29. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ. Res. 83 (1998) 1215-1223
30. + exchanger isoform 1, in an experimental model of cardiopulmonary bypass. Brit. J. Pharmacol. 142 (2004) 57-66
31. + exchanger using chymotryptic cleavage. Am. J. Physiol. Cell. Physiol. 275 (1998) C431-C439
32. Martindale J.J., Fernandez R., Thuerauf D., Whittaker R., Gude N., Sussman M.A., et al. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ. Res. 98 (2006) 1186-1193
33. Glembotski C.C. Endoplasmic reticulum stress in the heart. Circ. Res. 101 (2007) 975-984
34. Glembotski C.C. The role of the unfolded protein response in the heart. J. Mol. Cell. Cardiol. 44 (2008) 453-459
35. Vitadello M., Penzo D., Petronilli V., Michieli G., Gomirato S., Menabo R., et al. Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB. J. 17 (2003) 923-925
36. Shintani-Ishida K., Nakajima M., Uemura K., and Yoshida K. Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78. Biochem. Biophys. Res. Commun. 345 (2006) 1600-1605
37. Wu X., Liu X., Zhu X., and Tang C. Hypoxic preconditioning induces delayed cardioprotection through p38 MAPK-mediated calreticulin upregulation. Shock 27 (2007) 572-577
38. Severino A., Campioni M., Straino S., Salloum F.N., Schmidt N., Herbrand U., et al. Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. J. Am. Coll. Cardiol. 50 (2007) 1029-1037
39. Hamada H., Suzuki M., Yuasa S., Mimura N., Shinozuka N., Takada Y., et al. Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice. Mol. Cell. Biol. 24 (2004) 8007-8017
40. Boyce S.W., Bartels C., Bolli R., Chaitman B., Chen J.C., Chi E., et al. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J. Thorac. Cardiovasc. Surg. 126 (2003) 420-427
41. Mentzer R.M., Bartels C., Bolli R., Boyce S., Buckberg G.D., Chaitman B., et al. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann. Thorac. Surg. 85 (2008) 1261-1270
42. Wang X., and Robbins J. Heart failure and protein quality control. Circ. Res. 99 (2006) 1315-1328
43. Okada K., Minamino T., Tsukamoto Y., Liao Y., Tsukamoto O., Takashima S., et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110 (2004) 705-712
44. Kerkela R., Grazette L., Yacobi R., Iliescu C., Patten R., Beahm C., et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat. Med. 12 (2006) 908-916
45. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., et al. IRE1 signaling affects cell fate during the unfolded protein response. Science 318 (2007) 944-949
46. + exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am. J. Physiol. Heart. Circ. Physiol. 280 (2001) H738-H745
47. + exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits. Cardiovasc. Res. 63 (2004) 273-282
48. +-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc. Res. 65 (2005) 83-92
49. + exchange inhibitor, inhibits the mitochondrial death pathway. Circulation 108 (2003) 2275-2281
50. + exchanger. J. Biol. Chem. 273 (1998) 6951-6959
51. Miyazaki E., Sakaguchi M., Wakabayashi S., Shigekawa M., and Mihara K. NHE6 protein possesses a signal peptide destined for endoplasmic reticulum membrane and localizes in secretory organelles of the cell. J. Biol. Chem. 276 (2001) 49221-49227
52. Robbins J. Genetic modification of the heart: exploring necessity and sufficiency in the past 10 years. J. Mol. Cell. Cardiol. 36 (2004) 643-652